Fundraising Fox

DiaMedica Therapeutics

NASDAQ: DMAC

Minneapolis, US · Canada (Federal Level) corporation · 1 known investors

Biotech

Founders & leadership

DJ
David J. WambekeExecutive Officer
LM
Lorianne MasuokaExecutive Officer
RP
Rick PaulsExecutive Officer, Director
SK
Scott KellenExecutive Officer
PP
Paul PapiExecutive Officer
Z(
Zhenyu (Jerry) XiaoDirector
TV
Todd VerdoornExecutive Officer
DG
David GurveyExecutive Officer
CP
Charles P. SembaDirector
RK
Richard KuntzDirector
RM
R. Michael GiuffreDirector
TN
Tanya N. LewisDirector

Investors · 1

Shepherd VenturesreportedSan Diego · $750K – $3Mvia Richard P. Kuntz · board

Reported raises · per SEC filings

Form D private placements
▶$30.1MraisedJul 2025 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David J. WambekeExecutive Officer
  • Charles P. SembaDirector
  • Lorianne MasuokaExecutive Officer
  • Daniel O'ConnorDirector
  • Scott KellenExecutive Officer
  • Richard KuntzDirector
  • Michael R. GiuffreDirector
  • Tanya N. LewisDirector
  • Rick PaulsExecutive Officer, Director
  • James T. ParsonsDirector
Offering amount
$30.1M
Amount sold
$30.1M
First sale
Jul 2025
Incorporated
Corporation, Canada (federal Level)
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$11.8MraisedJul 2024 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David J. WambekeExecutive Officer
  • Charles P. SembaDirector
  • Richard KuntzDirector
  • R. Michael GiuffreDirector
  • Lorianne MasuokaExecutive Officer
  • Tanya N. LewisDirector
  • Rick PaulsExecutive Officer, Director
  • Scott KellenExecutive Officer
  • Richard D. PilnikDirector
  • James T. ParsonsDirector
Offering amount
$11.8M
Amount sold
$11.8M
First sale
Jun 2024
Incorporated
Corporation, Canada (federal Level)
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$37.5MraisedJun 2023 · 34 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dominic CundariExecutive Officer
  • Scott KellenExecutive Officer
  • David J. WambekeExecutive Officer
  • R. Michael GiuffreDirector
  • Rick PaulsExecutive Officer, Director
  • Richard D. PilnikDirector
  • Tanya N. LewisDirector
  • Julie DavesExecutive Officer
  • Kirsten GruisExecutive Officer
  • James T. ParsonsDirector
  • Richard KuntzDirector
  • Charles P. SembaDirector
Offering amount
$37.5M
Amount sold
$37.5M
Sales commissions
$845.8K
Placement agents
Craig-Hallum Capital Group LLC
First sale
Jun 2023
Incorporated
Corporation, Canada (federal Level)
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$750KraisedApr 2023 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Julie DavesExecutive Officer
  • Tanya N. LewisDirector
  • Scott KellenExecutive Officer
  • Rick PaulsExecutive Officer, Director
  • Kirsten GruisExecutive Officer
  • Charles P. SembaDirector
  • Dominic CundariExecutive Officer
  • Richard D. PilnikDirector
  • James T. ParsonsDirector
  • R. Michael GiuffreDirector
Offering amount
$750K
Amount sold
$750K
First sale
Apr 2023
Incorporated
Corporation, Canada (federal Level)
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$30MraisedOct 2021 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • R. Michael GiuffreDirector
  • Amy L. BurroughsDirector
  • Harry W. Alcorn Jr.Executive Officer
  • Richard D. PilnikDirector
  • Charles P. SembaDirector
  • Scott KellenExecutive Officer
  • Rick PaulsExecutive Officer, Director
  • Sydney GilmanExecutive Officer
  • James T. ParsonsDirector
Offering amount
$30M
Amount sold
$30M
First sale
Sep 2021
Incorporated
Corporation, Canada (federal Level)
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$200.9KraisedApr 2018 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Rick PaulsExecutive Officer, Director
  • James ParsonsDirector
  • Scott KellenExecutive Officer
  • Paul PapiExecutive Officer
  • Zhenyu (Jerry) XiaoDirector
  • Todd VerdoornExecutive Officer
  • Richard PilnikDirector
  • David GurveyExecutive Officer
  • Michael GiuffreDirector
Offering amount
$344.3K
Amount sold
$200.9K
First sale
Mar 2018
Incorporated
Corporation, Canada (federal Level)
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.